SYLVIA PEREZ: Open Payments
NPI 1225037666 · LIVERMORE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 9 payments from 4 companies in 2025. Trend: 2023 $152 · 2024 $235 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $169 |
| Alkermes, Inc. | 1 | $112 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: INGREZZA, CAPLYTA, LYBALVI, REXULTI.
Industry payments across CO — which companies pay providers there.
